MedPath

SPIKEVAX

SPIKEVAX

Discontinued
DIN Number

02527685

Drug Class

Human

Market Date

Jul 14, 2022

Company
HC

moderna biopharma canada corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02527685
AIG Number0162662002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BN01 COVID-19, RNA-BASED VACCINE
Product Specifications
Dosage FormDispersion
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ELASOMERANActive
Strength: 0.1 MG / ML
Monograph: ELASOMERAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.